AREVA Med

Titre

decorative

About AREVA Med

AREVA Med is an AREVA subsidiary specializing in the development of innovative new therapies to fight cancer.

decorative

How it works

Learn how the nuclear therapy works, what is lead-212 (212Pb), and about our ongoing research.

decorative

Clinical Trials

The Phase I clinical trials of lead-212 is currently taking place in the United States.

decorative

News & Materials

Read about the latest news and events, and download brochures and fact sheets.

decorative

Macrocyclics

Macrocyclics, part of AREVA Med, is the global leader in chelating agent technologies for medicine.

Latest News

Macrocyclics to Collaborate with Roche on Molecular Innovation for Nuclear Medicine

05/22/2013

Macrocyclics to Collaborate with Roche on Molecular Innovation for Nuclear Medicine

Read more
AREVA Med Presents Pharmacokinetics Data from Phase 1 Clinical Trial at SNMMI

05/16/2013

AREVA Med Presents Pharmacokinetics Data from Phase 1 Clinical Trial at SNMMI

Read more
The Ecole Supérieure de Design de Troyes and AREVA Med sign a partnership agreement for the industrialization of new equipment to be used in the fight against cancer

09/19/2012

The Ecole Supérieure de Design de Troyes and AREVA Med sign a partnership agreement for the industrialization of new equipment to be used in the fight against cancer

Read more
Contact

For more information about AREVA Med, please contact:
Alison Bedford
Tel.: + 1 (301) 841-1673

Contact

For more information about Macrocyclics, please contact:

Garry Kiefer

Tel.: + 1 (972) 250-2248

Linked In
decorative

Follow AREVA Med on

Join Our Team!
decorative

AREVA Med is seeking a Clinical Research Associate / Project Manager for our Dallas, TX, location.  For a complete job listing, please visit

Join Our Team!
decorative

AREVA Med is seeking a scientist to work at the Maurice Tubiana Facility in Bessines (France).  For details, please visit